The breast reconstruction market size in Europe is anticipated to be worth USD 182.1 million by 2027 from USD 133.5 million in 2022, growing at a CAGR of 6.39% from 2022 to 2027.
Y-O-Y growth in the number of breast cancer cases across Europe that require reconstruction, especially in women, is propelling the European breast reconstruction market. According to the World Health Organization (WHO), an estimated 2.3 million women were diagnosed with breast cancer and 685,000 died from breast cancer in 2020. The number keeps rising yearly in the European region. Breast cancer can leave the breasts in a complex shape and size, leading to the requirement for reconstruction. As a result, breast reconstruction plays a prominent role in breast cancer therapy, increasing patients' quality of life by restoring femininity for female breast cancer patients.
The growing awareness regarding breast reconstruction surgeries among women is contributing to the market growth in Europe. The working and independent population of women may prefer reconstruction for more confidence in stature and appearance, even more so if they have been through a mastectomy. Furthermore, one in seven women may have a life-threatening risk due to breast cancer, so they prefer to have a diagnosis. On the other hand, nearly 70-80 percent of the cancer are curable with early diagnosis, and it is essential to have regular check-ups to detect the problem.
The availability of reimbursement policies for breast reconstruction in Europe favors the market’s growth rate. Germany has a favorable system of reimbursement for chronic diseases, and the population heavily depends on these reimbursements for various treatment procedures. Additionally, several changes have been made to the reimbursement policies so that people can opt for reconstruction breast surgeries at an affordable cost in hospitals. Furthermore, the growing R&D activities around breast reconstruction, increasing clinical research for various types of breast reconstructing procedures, and the presence of market participants in the European region are promoting market expansion in Europe. Developing breast enhancement with different materials for reconstruction surgeries is some other factors driving the market forward.
However, increasing alternatives to breast reconstruction which do not require surgical procedures are hampering the regional market growth. In addition, the high costs associated with breast reconstruction surgeries are inhibiting the market's growth rate in Europe. In addition, side effects associated with breast reconstruction and the lack of skilled professionals hinder the market growth.
This research report on the Europe breast reconstruction market has been segmented and sub-segmented into the following categories.
By Product:
Based on product, the implants segment is anticipated to hold the most significant share of the European market during the forecast period, and the tissue expander segment is predicted to showcase the fastest CAGR in the European market during the forecast period.
By Shape:
Based on shape, the round segment accounted for the largest share of the European breast reconstruction market in 2021.
By End-Use:
Based on end-use, the hospital segment captured the major share of the European breast reconstruction market in 2021 and is expected to continue holding the leading share of the European market in the coming years. On the other hand, the cosmetology clinics and ASCs segments had a considerable share of the European market in 2021.
By Country:
The European region accounted for a substantial share of the worldwide market in 2021. The European market is also expected to have promising occupancy in the worldwide market during the forecast period. The growth of the European market is primarily attributed to the growing number of breast reconstruction procedures, increasing adoption of technological developments, and rising willingness of people to have breast reconstruction. In addition, there has been a significant rise in the number of training centers for breast reconstruction surgeries. After the specialization in training, the trainees are awarded certification giving them eligibility to treat breast cancer. There have also been multiple initiatives by the governments to raise awareness regarding breast cancer and improve healthcare services toward reconstruction procedures. For example, the European Breast Cancer Conference discussed reimbursement policies for breast cancer. Breast Reconstruction Awareness Day was also conducted on October 19 every year to educate women about post-cancer breast reconstruction options.
Germany is expected to hold a significant share of the European market during the forecast period. Approximately 25% of women who undergo a mastectomy in Germany require a breast reconstruction procedure. Increasing awareness programs about breast reconstruction by the government and women's welfare organizations to spread awareness regarding the process and benefits of having breast reconstruction surgeries encourage women to opt for the procedure leading to market growth in the UK.
The UK is another potential market for breast reconstruction in the European region. In the United Kingdom, researchers are working on reconstruction surgeries by conducting surveys on women undergoing cancer treatment and have further plans of having reconstruction surgery. In addition, healthcare researchers are focusing on developing new equipment for breast reconstruction surgeries, reducing the time taken for the surgery and fast recovery. Additionally, the new technologies in the field support the region’s growth. For example, 3D implants are a new development in breast reconstruction surgery, also known as computer-aided manufacturing (CAM), developed based on different models such as plastic and other adhesive material.
KEY MARKET PARTICIPANTS:
Johnson & Johnson, Allergan Inc., Sientra Inc., Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, TI Surgical Holdings, Sebbin, Integra LifeSciences, GC Aesthetics, and Ideal Implant Incorporated are some of the notable companies in the European breast reconstruction market.
Frequently Asked Questions
In 2022, the European breast reconstruction market is expected to be worth USD 133.5 million.
Germany is forecasted to play a major role in the European market during the forecast period.
UK is expected to showcase fastest CAGR in the European market during the forecast period.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region